SHANGHAI SHYNDEC PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 600420 for the last quarter is 2.87 B CNY, and it's 6.65% higher compared to the previous quarter. The net income of Q4 23 is 127.96 M CNY.